Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor Primes Neonatal Granulocytes for Enhanced Oxidative Metabolism and Chemotaxis

ABSTRACT: Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) induces proliferation and differentiation of hematopoietic stem cells. Additionally, rhGM-CSF enhances the physiologic responses of adult polymorphonuclear leukocytes (PMN) especially with respect to oxidative metabolism and chemotaxis. Neonatal PMN are deficient in chemotaxis and have been demonstrated to have reduced oxidative responses in times of stress. We evaluated the priming effects of rhGMCSF (1-100 pmol/L) on cord (neonatal) superoxide production and chemotaxis. Cord and adult PMN were incubated with 100 pmol/L rhGM-CSF (Amgen, 4 × 107 U/mg) for 0-120 min and stimulated with N-formyl-1-methionyl- 1-leucyl-phenylalanine. RhGM-CSF enhanced O2− production at all time periods with maximal priming at 60 min (147.97 ± 11.14% p ≤ 0.006) with less, but significant enhancement at 120 min (116.53 ± 7.92% p ≤ 0.05). Maximal adult PMN O2− release occurred at 120 min (190.02 ± 8.71% p ≤ 0.003) and was more pronounced than cord PMN. RhGM-CSF (100 pmol/L × 30 min) incubation of cord PMN also primed for increased PMN O2− release after zymosan-activated serum stimulation (p ≤ 0.05) but not PMA (p = NS). Co-incubating cord PMNs with 100 pmol/L rhGM-CSF and a murine anti-human GM-CSF antibody (0-100 mcg/ml) resulted in 95% inhibition of the priming effect of rhGM-CSF enhancement of cord PMN (V release. RhGM-CSF, primed cord PMN for enhanced chemotaxis during early incubation (5 min) with both N-formyl-1-methionyl-l-leucyl-phenylalanine (10∼8 M) and Escherichia coli filtrate (113.54 ± 6.11% p ≤ 0.025 and 110.84 ± 4.69% p ≤ 0.001), respectively, but not at 30-min or 60-min incubation. These studies suggest that rhGM-CSF similarly primes neonatal PMN like adult PMN for enhanced in vitro PMN oxidative responses and chemotaxis.

[1]  S. Cannistra,et al.  Regulation of the production and function of granulocytes and monocytes. , 1988, Seminars in hematology.

[2]  J. Dipersio,et al.  Granulocyte-macrophage colony-stimulating factor modulates the excitation-response coupling sequence in human neutrophils. , 1988, Journal of immunology.

[3]  D. Golde,et al.  Granulocyte-macrophage colony-stimulating factor enhances neutrophil function in acquired immunodeficiency syndrome patients. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A. D. de Weck,et al.  Leukotriene production in human neutrophils primed by recombinant human granulocyte/macrophage colony-stimulating factor and stimulated with the complement component C5A and FMLP as second signals , 1988, The Journal of experimental medicine.

[5]  A. Komiyama,et al.  Increased production of superoxide anion by neonatal polymorphonuclear leukocytes stimulated with a chemotactic peptide , 1988, American journal of hematology.

[6]  J. Griffin,et al.  Effects of recombinant human granulocyte and macrophage colony-stimulating factors on signal transduction pathways in human granulocytes. , 1987, Journal of immunology.

[7]  H. Hill.  Biochemical, Structural, and Functional Abnormalities of Polymorphonuclear Leukocytes in the Neonate , 1987, Pediatric Research.

[8]  E. Liehl,et al.  Recombinant human GM-CSF induces leukocytosis and activates peripheral blood polymorphonuclear neutrophils in nonhuman primates. , 1987, Blood.

[9]  R. Kamen,et al.  The human hematopoietic colony-stimulating factors. , 1987, Science.

[10]  M. Cairo,et al.  Role of circulating complement and polymorphonuclear leukocyte transfusion in treatment and outcome in critically ill neonates with sepsis. , 1987, The Journal of pediatrics.

[11]  C. Sieff.  Hematopoietic growth factors. , 1987, The Journal of clinical investigation.

[12]  D. Golde,et al.  Human GM-CSF primes neutrophils for enhanced oxidative metabolism in response to the major physiological chemoattractants. , 1987, Blood.

[13]  D. Golde,et al.  Biosynthetic human GM-CSF modulates the number and affinity of neutrophil f-Met-Leu-Phe receptors. , 1986, Journal of immunology.

[14]  D. Golde,et al.  Granulocyte-macrophage colony-stimulating factor enhances phagocytosis of bacteria by human neutrophils. , 1986, Blood.

[15]  M. Arnaout,et al.  Human recombinant granulocyte-macrophage colony-stimulating factor increases cell-to-cell adhesion and surface expression of adhesion-promoting surface glycoproteins on mature granulocytes. , 1986, The Journal of clinical investigation.

[16]  J. Katz,et al.  Impaired in vitro polymorphonuclear function secondary to the chemotherapeutic effects of vincristine, adriamycin, cyclophosphamide, and actinomycin D. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  P. Krause,et al.  Polymorphonuclear Leukocyte Adherence and Chemotaxis in Stressed and Healthy Neonates , 1986, Pediatric Research.

[18]  M. Tomonaga,et al.  High-affinity binding of granulocyte-macrophage colony-stimulating factor to normal and leukemic human myeloid cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[19]  C. Wilson,et al.  Immunologic basis for increased susceptibility of the neonate to infection. , 1986, The Journal of pediatrics.

[20]  R. Donahue,et al.  Human recombinant granulocyte-macrophage colony-stimulating factor: a multilineage hematopoietin. , 1985, Science.

[21]  E. Brown,et al.  Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins. , 1985, Science.

[22]  D. Golde,et al.  Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator , 1985, Nature.

[23]  D. Golde,et al.  Purified human granulocyte-macrophage colony-stimulating factor: direct action on neutrophils. , 1984, Science.

[24]  H. Hill,et al.  Defective oxidative metabolic responses of neutrophils from stressed neonates , 1981, The Journal of pediatrics.

[25]  R. Johnston,et al.  Defective oxidative metabolism in newborn neutrophils: discrepancy between superoxide anion and hydroxyl radical generation. , 1979, Pediatrics.

[26]  H. Hill,et al.  Functional analysis of neutrophil granulocytes from healthy, infected, and stressed neonates. , 1979, The Journal of pediatrics.

[27]  R. A. Clark,et al.  Granulocyte chemotaxis: an improved in vitro assay employing 51 Cr-labeled granulocytes. , 1973, Journal of immunology.

[28]  Michael E. Miller.  Chemotactic Function in the Human Neonate: Humoral and Cellular Aspects , 1971, Pediatric Research.

[29]  M. Miller.  Phagocytosis in the newborn infant: humoral and cellular factors. , 1969, The Journal of pediatrics.

[30]  J. White,et al.  In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. , 1967, The Journal of clinical investigation.